Vincent Medical Holdings Ltd
HKEX:1612
Intrinsic Value
Vincent Medical Holdings Ltd. engages in the manufacture and sale of medical devices. [ Read More ]
The intrinsic value of one Vincent Medical Holdings Ltd stock under the Base Case scenario is 0.89 HKD. Compared to the current market price of 0.38 HKD, Vincent Medical Holdings Ltd is Undervalued by 57%.
Valuation Backtest
Vincent Medical Holdings Ltd
Run backtest to discover the historical profit from buying and selling Vincent Medical Holdings Ltd stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Vincent Medical Holdings Ltd
Current Assets | 572.7m |
Cash & Short-Term Investments | 175.8m |
Receivables | 187.2m |
Other Current Assets | 209.7m |
Non-Current Assets | 214m |
Long-Term Investments | 32.8m |
PP&E | 149m |
Intangibles | 4.8m |
Other Non-Current Assets | 27.3m |
Current Liabilities | 236.6m |
Accounts Payable | 59.9m |
Short-Term Debt | 21m |
Other Current Liabilities | 155.7m |
Non-Current Liabilities | 8.1m |
Long-Term Debt | 1.8m |
Other Non-Current Liabilities | 6.3m |
Earnings Waterfall
Vincent Medical Holdings Ltd
Revenue
|
718m
HKD
|
Cost of Revenue
|
-477.6m
HKD
|
Gross Profit
|
240.4m
HKD
|
Operating Expenses
|
-173.3m
HKD
|
Operating Income
|
67.1m
HKD
|
Other Expenses
|
-9.8m
HKD
|
Net Income
|
57.3m
HKD
|
Free Cash Flow Analysis
Vincent Medical Holdings Ltd
Profitability Score
Profitability Due Diligence
Vincent Medical Holdings Ltd's profitability score is 49/100. The higher the profitability score, the more profitable the company is.
Score
Vincent Medical Holdings Ltd's profitability score is 49/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Vincent Medical Holdings Ltd's solvency score is 74/100. The higher the solvency score, the more solvent the company is.
Score
Vincent Medical Holdings Ltd's solvency score is 74/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Vincent Medical Holdings Ltd
According to Wall Street analysts, the average 1-year price target for Vincent Medical Holdings Ltd is 0.67 HKD with a low forecast of 0.67 HKD and a high forecast of 0.69 HKD.
Shareholder Return
Price
Vincent Medical Holdings Ltd
Average Annual Return | 36.48% |
Standard Deviation of Annual Returns | 124.34% |
Max Drawdown | -89% |
Market Capitalization | 248.3m HKD |
Shares Outstanding | 653 336 330 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Vincent Medical Holdings Ltd. engages in the manufacture and sale of medical devices. The company employs 1,281 full-time employees The company went IPO on 2016-07-13. The firm and its subsidiaries are principally engaged in the research, development, manufacture and trade of medical devices. The Company’s products include respiratory products, Orthopaedics & Rehabilitation Products and other medical devices. The Company’s subsidiaries includes Vincent Medical Manufacturing Holdings Limited, Vincent Medical Care Holdings Limited, Vincent Medical (GuangZhou) R&D Limited, VINCENT HEALTHCARE PRODUCTS LIMITED, VINCENT MEDICAL CARE COMPANY LIMITED, Vincent Medical (Dongguan) Mfg. Co. LTD., as well as VINCENT MEDICAL MANUFACTURING CO., LIMITED, among others.
Contact
IPO
Employees
Officers
The intrinsic value of one Vincent Medical Holdings Ltd stock under the Base Case scenario is 0.89 HKD.
Compared to the current market price of 0.38 HKD, Vincent Medical Holdings Ltd is Undervalued by 57%.